Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene

被引:277
作者
Brogan, IJ [1 ]
Khan, N [1 ]
Isaac, K [1 ]
Hutchinson, JA [1 ]
Pravica, V [1 ]
Hutchinson, IV [1 ]
机构
[1] Univ Manchester, Sch Biol Sci, Immunol Res Grp, Manchester M13 9PT, Lancs, England
关键词
gene polymorphism; promoter; VEGF; 5 ' UTR;
D O I
10.1016/S0198-8859(99)00132-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have characterized 5 novel, single-nucleotide polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor (VEGF) gene. Transitions C --> A at nucleotide position -2578 relative co the translation start sire, T --> C at position -1455, G --> A at position -1154, G --> C at position -1001, and C --> T at position -7 were observed. In addition, individuals with the A allele at position -2578 also had an insertion of 18 nucleotides, whereas CC homozygotes did not contain this insert ion. We have described the frequency distribution of the poly-morphic alleles in the population of healthy volunteers and are investigating the functional significance of the 18-nucleotide insertion and of the single-nucleotide polymorphisms on VEGF gene expression. (C) American Society for Histocompatibility and Immunogenetics, 1999. Published by Elsevier Science Inc.
引用
收藏
页码:1245 / 1249
页数:5
相关论文
共 20 条
[1]   Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription [J].
Akiri, G ;
Nahari, D ;
Finkelstein, Y ;
Le, SY ;
Elroy-Stein, O ;
Levi, BZ .
ONCOGENE, 1998, 17 (02) :227-236
[2]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[3]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[4]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[5]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[6]  
FREEMAN MR, 1995, CANCER RES, V55, P4140
[7]  
HUTCHINSON IV, 1998, GRAFT, V1, P186
[8]  
IIJIMA K, 1992, KIDNEY INT, V42, P1457
[9]  
Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5
[10]   HYPOXIA REGULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE-EXPRESSION IN ENDOTHELIAL-CELLS - IDENTIFICATION OF A 5'-ENHANCER [J].
LIU, YX ;
COX, SR ;
MORITA, T ;
KOUREMBANAS, S .
CIRCULATION RESEARCH, 1995, 77 (03) :638-643